University of Utah
Salt Lake City, Utah, 84112, United States
NCT Number: NCT02962557
This study will explore the feasibility of an idea to use standard, FDA-approved patient monitors to detect ventilatory depression and then play a recorded nurse's voice to prompt patients by name to breathe. The voice prompt will occur in addition to when the traditional alarms are sounded by the monitors. The study device consists of commercially available physiologic monitors, a speaker, and a laptop computer. The physiologic monitors include a pulse oximeter with a motion sensor, capnometer, and nasal airway pressure sensor (built into a nasal cannula). Nasal pressure is a commonly used clinical monitor for sleep apnea detection during polysomnography testing in sleep labs.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Salt Lake City, Utah, 84112, United States
This study will explore the feasibility of an idea to use standard, FDA-approved patient monitors to detect ventilatory depression and then play a recorded nurse's voice to prompt patients by name to breathe. The voice prompt will occur in addition to when the traditional alarms are sounded by the monitors. The study device consists of commercially available physiologic monitors, a speaker, and a laptop computer. The physiologic monitors include a pulse oximeter with a motion sensor, capnometer, and nasal airway pressure sensor (built into a nasal cannula). Nasal pressure is a commonly used clinical monitor for sleep apnea detection during polysomnography testing in sleep labs.
The study will be conducted in patients that are admitted to the hospital following surgery. Patients will be monitored during the first 24 hours after surgery, first in the recovery room (post anesthesia care unit, or PACU) and then on the hospital floor. The study will enroll patients with a high likelihood of experiencing ventilatory depression and/or partial to complete airway obstruction. This patient group includes those with known or suspected obstructive sleep apnea and those with surgeries associated with moderate to severe postoperative pain that require significant opioid administration after surgery. The study will compare effectiveness of prompting patients to breathe to that of routine clinical practice in the PACU and hospital floor. The hypothesis is that when compared to standard monitoring and interventions by clinical staff, the digitized breath prompting will prompt patients to breathe more quickly, which will lead to higher oxygen-hemoglobin saturations and respiratory rates throughout the first 24 hours of a patient's hospital stay following surgery.
For patient safety purposes, the experimental design of this study will implement this device as a shadow monitor. Patients will be instrumented with standard physiologic monitors per routine practice in each hospital location (PACU and floor). There will be no change in how clinical staff interacts with patients (i.e. prompting to breathe, checking vital signs, administering medications, assessing patient well-being, etc.) Clinical staff may disable the device at any time if patient comfort or safety are in question.
This study involves use of already cleared medical devices in which they are used in accordance with the indications in the cleared labeling. What is unique is that output from these monitoring devices will be used to prompt a patient directly by name to breathe. The goal of this study is to test the feasibility of the idea that patients will respond to prompts to breathe by a digitized prompting system. If the concept is successful in patients after surgery, as it was for healthy volunteers in previous testing, future research steps would include designing a device and testing it in a clinical trial on patients on the general floor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients that meet the following criteria will be invited to participate in this study:
OR
Nurses who meet the following criteria will be invited to participate in this study:
PACU nurses who are in charge of caring for consented patients.
Exclusion criteria
The device used is the NM3 by Phillips Medical, Wallingford CT. The prompting for breaths will include a recorded voice played at 100 decibels played by a speaker placed within 4 feet of the patient's head. If successful breath response is monitored by the patient monitors but no additional subsequent breaths occur within 20 seconds, the verbal prompt will be repeated for the patient to breathe. If the verbal prompting does not result in a breath detected by the patient monitors, the verbal prompt will be repeated within 20 seconds, optionally accompanied by a shoulder shake from the shoulder massager.
Time frame: Average and median SpO2 will be measured every 10 minutes for approximately the first 24 hours after surgery during the patient's stay
Time frame: Change in respiratory rate from baseline to the period 10 seconds after the breath prompt every 10 minutes for approximately the first 24 hours after surgery during the patient's stay
Time frame: Average and median respiratory rate will be measured every 10 minutes for approximately the first 24 hours after surgery during the patient's stay
Time frame: Average and median etCO2 will be measured every 10 minutes for approximately the first 24 hours after surgery during the patient's stay
University of Utah
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06249659
Anesthesia, Complication,Postoperative
Clermont-Ferrand, France
View Trial DetailsNCT02987985
Analgesics, Analgesics, Opioid
Saskatoon, Saskatchewan, Canada
View Trial DetailsNCT03858257
Anesthesia, Cardiac Disease
Toronto, Ontario, Canada
View Trial DetailsNCT07719439
Adenotonsillar Hypertrophy, Adverse Cardiac Event
Düzce, Turkey (Türkiye)
View Trial Details